<DOC>
	<DOC>NCT02174822</DOC>
	<brief_summary>To assess steady state pharmacokinetics (PK), safety and tolerability between AVP-786 (deuterated [d6] dextromethorphan hydrobromide [DM]/quinidine sulfate [Q]) and paroxetine and between AVP-786 and duloxetine.</brief_summary>
	<brief_title>A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Quinidine</mesh_term>
	<criteria>Healthy adult males and females 18 50 years of age BMI 18 30 kg/m2 History or presence of significant disease History of substance abuse and/or alcohol abuse with the past 3 years Use of tobaccocontaining or nicotinecontaining products within 6 months Use of any prescription or the overthecounter medications within 14 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Drug-drug interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>deuterated dextromethorphan</keyword>
	<keyword>deuterated dextromethorphan with quinidine</keyword>
</DOC>